Clinical Trial Update: A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating a minimally invasive approach to cytoreduction and HIPEC for peritoneal surface malignancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University of California, San Diego | Conditions: Cancer | Phase 2 | Status: COMPLETED